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BACKGROUND 
OBJECTIVES 
CONCLUSIONS RESULTS 
• To quantify the incidence of malignancy in women 
undergoing hysterectomy for benign indications with and 
without morcellation 
 
• To compare the preoperative evaluation of patients 
undergoing hysterectomy with and without morcellation 
 
Subjects 
• All women having a hysterectomy between October 2007 
and June 2014 were identified by billing procedure 
codes.  
 
Methods 
• This retrospective cohort study was a medical record 
review of 2,332 charts.  
• Chart abstraction included demographics; pre-
hysterectomy evaluation, including current cervical 
cytology, pathologic endometrial assessment (biopsy, 
dilation and curettage), and imaging (ultrasound, MRI, CT 
scan, sonohysterogram, or hysteroscopy); intraoperative 
factors; and final diagnosis. 
Demographics 
• The cohort included 2,332 women undergoing hysterectomy with 396 (17.0%) including use of morcellation. 
• Women were aged 48.3 ± 10.2 years at the time of surgery, and 33.7% of the population was post-menopausal. 
 
Malignancy Incidence 
• The incidence of malignancy on final pathology was 2.1% and was different between non-morcellated versus 
morcellated specimens (2.5% vs. 0.3%, p<0.001).  
 
Pre-operative Evaluation 
• There was no significant difference in current cervical cytology (68.9% vs. 71.3%) and imaging (39.6% vs. 34.9%) 
rates between the non- versus morcellated groups; however those experiencing morcellation were less likely to have 
preoperative pathologic endometrial assessment (21.7% vs. 34.2%, p<0.001).    
Table 1.  
Figure 1.  
• The incidence of malignancy at time of 
hysterectomy performed by non-oncology trained 
gynecologists was 2.1% overall, and 0.3% in 
morcellated cases.  
 
• The pre-operative evaluation of patients 
undergoing hysterectomy with morcellation was 
similar to those without morcellation, except for 
lower rates of pathologic endometrial assessment 
by dilation and curettage or endometrial biopsy. 
  
• The lower rates of endometrial assessment seen in 
the morcellation group can be explained by the 
fewer chief complaints of abnormal uterine 
bleeding and more pre-operative diagnoses of 
pelvic organ prolapse.  
 
• An argument could be made that a pathology 
assessment is indicated in the group undergoing 
hysterectomy with morcellation due to risk of 
dissemination in the case of occult malignancy.  
 
• The risk of occult malignancy is rare, but this should 
be discussed with patients and taken into account 
during the pre-operative evaluation.  
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REFERENCES 
• Hysterectomy is one of the most commonly performed 
surgical procedures in the U.S., with minimally invasive 
approaches being preferred. 
 
• The use of power morcellation in gynecologic surgery has 
come under scrutiny secondary to concerns for occult 
malignancy dissemination.1  
 
• The incidence of undiagnosed gynecologic malignancy 
when hysterectomies are performed for benign 
indications is not definitive but has been quoted as high 
as 2.7% (1:37).2  
 
• There is no standard recommended preoperative 
evaluation, and variation is anticipated by preoperative 
complaint or diagnosis.3  
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Malignant 49 (2.1%) 1 (0.3%) 48 (2.5%) 
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